CLINICAL_TRIALS
trial_result
· 2017-12-05
Clinical Trial Update: Reversing Ticagrelor's Effects With Fresh Platelets [Phase 4]
Summary
A Phase 4 trial assesses whether transfusing fresh platelets can reverse the antiplatelet effects of ticagrelor in patients with coronary artery disease.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Icahn School of Medicine at Mount Sinai | Conditions: Coronary Artery Disease | Phase 4 | Status: COMPLETED | Results posted: 2017-12-05